News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Johnson & Johnson (JNJ) Exec Will Become Boston Scientific Corporation (BSX) CEO


9/14/2011 7:00:41 AM

Boston Scientific Corp (NYSE:BSX - News) named Johnson & Johnson (NYSE:JNJ - News) executive Michael Mahoney as its new president and chief executive, replacing Ray Elliott, who announced in May he intended to step down. Mahoney, 46, who has served as chairman of J&J's medical device and diagnostics business, will become Boston Scientific's president on October 17 and is expected to become CEO next year on Nov 1, 2012, to accommodate post-employment obligations with J&J, Boston Scientific said.

Read at Reuters
Read at AP
Read at Wall Street Journal
Read at BusinessWeek


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES